Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $12,353 | reported | |
| FY 2024 | 2024-12-31 | $3,470 | reported | |
| FY 2023 | 2023-12-31 | $604,676 | reported | |
| FY 2022 | 2022-12-31 | $104,283 | reported | |
| FY 2021 | 2021-12-31 | $1,244,373 | reported | |
| FY 2020 | 2020-02-29 | $0 | reported | |
| FY 2019 | 2019-02-28 | $0 | reported | |
| FY 2018 | 2018-02-28 | $0 | reported | |
| FY 2017 | 2017-02-28 | $0 | reported | |
| FY 2016 | 2016-02-29 | $0 | reported | |
| FY 2015 | 2015-02-28 | $0 | reported | |
| FY 2014 | 2014-02-28 | $0 | reported |
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
Yubo International Biotech Ltd is the 28th largest of the 33 covered companies the SEC files under this code, by revenue. SIC 3845
Latest filing Aug 14, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
No Form 13F holders on file yet.
No reported open-market purchases or sales in the last 12 months.